419 related articles for article (PubMed ID: 29339549)
1.
Doshi MD; Ortigosa-Goggins M; Garg AX; Li L; Poggio ED; Winkler CA; Kopp JB
J Am Soc Nephrol; 2018 Apr; 29(4):1309-1316. PubMed ID: 29339549
[TBL] [Abstract][Full Text] [Related]
2. Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
Mena-Gutierrez AM; Reeves-Daniel AM; Jay CL; Freedman BI
Transplantation; 2020 Jan; 104(1):27-32. PubMed ID: 31449181
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
[TBL] [Abstract][Full Text] [Related]
4. Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype.
Chen DP; Henderson CD; Anguiano J; Aiello CP; Collie MM; Moreno V; Hu Y; Hogan SL; Falk RJ;
Clin J Am Soc Nephrol; 2023 Mar; 18(3):337-343. PubMed ID: 36763808
[TBL] [Abstract][Full Text] [Related]
5. GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.
Matas AJ; Vock DM; Ibrahim HN
Am J Transplant; 2018 Mar; 18(3):625-631. PubMed ID: 28980397
[TBL] [Abstract][Full Text] [Related]
6. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.
Massie AB; Holscher CM; Henderson ML; Fahmy LM; Thomas AG; Al Ammary F; Getsin SN; Snyder JJ; Lentine KL; Garg AX; Segev DL
JAMA Surg; 2020 Mar; 155(3):e195472. PubMed ID: 31968070
[TBL] [Abstract][Full Text] [Related]
7.
Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Postdonation Kidney Function Between Caucasian Donors and Low-risk APOL1 Genotype Living Kidney Donors of African Ancestry.
Gaillard F; Gribouval O; Courbebaisse M; Fournier C; Antignac C; Legendre C; Servais A
Transplantation; 2018 Nov; 102(11):e462-e463. PubMed ID: 30247453
[No Abstract] [Full Text] [Related]
9. APOL1-Associated End-Stage Renal Disease in a Living Kidney Transplant Donor.
Zwang NA; Shetty A; Sustento-Reodica N; Gordon EJ; Leventhal J; Gallon L; Friedewald JJ
Am J Transplant; 2016 Dec; 16(12):3568-3572. PubMed ID: 27588375
[TBL] [Abstract][Full Text] [Related]
10. Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.
Holscher CM; Haugen CE; Jackson KR; Garonzik Wang JM; Waldram MM; Bae S; Locke JE; Reed RD; Lentine KL; Gupta G; Weir MR; Friedewald JJ; Verbesey J; Cooper M; Segev DL; Massie AB
Clin J Am Soc Nephrol; 2019 Oct; 14(10):1493-1499. PubMed ID: 31537534
[TBL] [Abstract][Full Text] [Related]
11. Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study.
Chen TK; Coresh J; Daya N; Ballew SH; Tin A; Crews DC; Grams ME
J Am Geriatr Soc; 2021 Jan; 69(1):155-163. PubMed ID: 32894582
[TBL] [Abstract][Full Text] [Related]
12. Risk of end-stage renal disease following live kidney donation.
Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
[TBL] [Abstract][Full Text] [Related]
13. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
[TBL] [Abstract][Full Text] [Related]
15. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
[TBL] [Abstract][Full Text] [Related]
16. Increase in 24-Hour Protein Excretion Immediately After Donation Is Associated With Decreased Functional Recovery in Living Kidney Donors.
Na JC; Yoon MG; Lee HH; Yoon YE; Kim DG; Huh KH; Kim YS; Han WK
Transplant Proc; 2019 Oct; 51(8):2543-2548. PubMed ID: 31473006
[TBL] [Abstract][Full Text] [Related]
17. External Validation of Toulouse-Rangueil eGFR12 Prediction Model After Living Donor Nephrectomy.
Patel SS; Lonze BE; Chiang TP; Al Ammary F; Segev DL; Massie AB
Transpl Int; 2023; 36():11619. PubMed ID: 37745642
[TBL] [Abstract][Full Text] [Related]
18.
Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
[TBL] [Abstract][Full Text] [Related]
19. Single-Center Long-Term Follow-Up of Kidney Donors in Argentina (Hospital Italiano de Buenos Aires).
Mombelli CA; Giordani MC; Imperiali NC; Groppa SR; Villamil Cortez SK; Schreck CM; Rosa-Diez GJ
Transplant Proc; 2018 Mar; 50(2):418-422. PubMed ID: 29579818
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.
Locke JE; Sawinski D; Reed RD; Shelton B; MacLennan PA; Kumar V; Mehta S; Mannon RB; Gaston R; Julian BA; Carr JJ; Terry JG; Kilgore M; Massie AB; Segev DL; Lewis CE
Ann Surg; 2018 Jun; 267(6):1161-1168. PubMed ID: 28187045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
